UnitedHealth: This Rally Is Lacking Substance; Sell Now

Group 1 - The article discusses the author's previous prediction regarding UnitedHealth's stock performance, stating it would continue to decline for the rest of the year, which has not materialized as expected [1] - The author emphasizes a generalist investment approach, focusing on sectors with perceived alpha potential compared to the S&P 500, with typical holding periods ranging from a few quarters to multiple years [1] - The research methodology includes maintaining comprehensive spreadsheets with historical financial data, key metrics, guidance trends, and performance indicators, while also monitoring industry news and reports [1] Group 2 - The author prefers not to build discounted cash flow (DCF) models for long-term projections, believing it adds limited value, and instead focuses on assessing a company's historical performance and outlook on key valuation drivers [1]